PhRMA
JUNE 15, 2023
I always look forward to the American Society of Clinical Oncology’s Annual Meeting, which took place in Chicago earlier this month. It’s an opportunity for the world’s leading cancer experts to celebrate the latest innovations that are changing the treatment paradigm for patients with this disease.
Drug Topics
JUNE 15, 2023
G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
JUNE 15, 2023
America’s biopharmaceutical research companies are central to the research and development (R&D) of innovative medicines in the United States. Unfortunately, a new report by Sen. Sanders mischaracterizes the role the National Institutes of Health plays in the research and development (R&D) process and risks stifling the innovative biopharmaceutical ecosystem vital to advancing medicines for patients.
Drug Topics
JUNE 15, 2023
The iLet Bionic Pancreas combines data from the Dexcom G6 CGM with different algorithms to deliver insulin throughout the day.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 15, 2023
Pharmacists can address the needs of health care consumers earlier in the care journey by building interpersonal relationships and community trust, as well as by leading institutional and public policy reform.
Drug Topics
JUNE 15, 2023
Meet this year’s Pharmacy of the Year nominees and preview some of the sessions available at this year’s meeting.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JUNE 15, 2023
Novo Nordisk is the only company with FDA-approved products containing semaglutide.
Fierce Healthcare
JUNE 15, 2023
Retail pharmacy giant Walgreens inked another partnership to recruit participants for research as it continues to build out its clinical trials business. | Retail pharmacy giant Walgreens inked another partnership to recruit participants for research as it continues to build out its clinical trials business.
Drug Topics
JUNE 15, 2023
What does the future of digital health look like?
Pharmacy Times
JUNE 15, 2023
Despite having a lower cost of development than the innovator, romiplostim biosimilar has comparable efficacy and safety in patients with chronic immune thrombocytopenia.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JUNE 15, 2023
The Covid-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by mutated versions as the virus rapidly evolves.
Pharmacy Times
JUNE 15, 2023
A broader understanding of vaccine hesitancy and barriers has helped to enhance acceptance of vaccination services through educational outreach.
Fierce Healthcare
JUNE 15, 2023
The former manager of a morgue at Harvard Medical School is up against federal charges for allegedly stealing, selling and shipping human body parts, federal prosecutors said Wednesday. | The former manager of a morgue at Harvard Medical School is up against federal charges for allegedly stealing, selling and shipping human body parts, federal prosecutors said on Wednesday.
Pharmacy Times
JUNE 15, 2023
Pharmacists can empower their community with essential knowledge for summer skin protection to protect against skin cancer.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JUNE 15, 2023
Not so long ago, a father broke down in tears with me over Zoom — tears of relief. When this father had received test results for his child, some of the values in the report appeared in red. That font color made him terrified for his child’s health. It was only when we hopped on Zoom to go over the results that I was able to reassure him: They were in red because the system was comparing them with adult range values.
Drug Topics
JUNE 15, 2023
When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.
STAT
JUNE 15, 2023
Tumor response rate is a common way to assess the efficacy of a cancer drug. It’s not a perfect measure, for sure, but it’s easy to calculate and understand — or it should be. PDS Biotech is a small developer of cancer drugs that is zealously seeking investor eyeballs, yet it can’t seem to grasp the tumor-response concept.
Drug Topics
JUNE 15, 2023
When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.
Pharmaceutical Technology
JUNE 15, 2023
Eloxx has revealed its lead candidate ELX-02 improved predicted forced expiratory volume (ppFEV1) in patients with Class 1 cystic fibrosis (CF) in a new analysis of a Phase II trial that missed its efficacy endpoints. Following underwhelming topline results from the Phase II trial (NCT04135495) announced in late 2022, Eloxx recalculated the results using the change in ppFEV1 (a secondary outcome) from day 1 instead of from baseline.
STAT
JUNE 15, 2023
The Centers for Disease Control and Prevention may be about to undergo a paradigm shift with the anticipated appointment of former North Carolina health secretary Mandy Cohen as the agency’s next director. The Atlanta-based CDC has always prided itself at being at a remove from Washington, and the politics that engulf it. With 634 miles separating the U.S.
Fierce Pharma
JUNE 15, 2023
While demand for COVID-19 vaccines has plummeted throughout 2023, healthcare officials remain focused on ensuring that the most effective shots are available for those who need them. | While demand for COVID-19 vaccines has plummeted throughout 2023, healthcare officials remain focused on ensuring that the most effective shots are available for those who need them.
STAT
JUNE 15, 2023
The invite list for the White House’s upcoming “summit” on naloxone pricing and accessibility has some noteworthy omissions. Two of the most prominent organizations focused on providing cheaper overdose-reversal medications will be conspicuously absent from Tuesday’s event : Harm Reduction Therapeutics, a nonprofit drug manufacturer currently seeking approval for a naloxone nasal spray, and Remedy Alliance, a group that distributes cheap naloxone to harm-reduction gro
Hospital Pharmacy Europe
JUNE 15, 2023
Vorasidenib improves progression-free survival in patients with residual or recurrent grade 2 glioma, according to a recent double-blind, placebo-controlled trial. Diffuse gliomas represent 75% of all primary malignant brain tumours in adults and are both locally aggressive and currently incurable. Moreover, mutations in the isocitrate dehydrogenases (IDHs) encoded by IDH1 and IDH2 are present in the majority of malignant gliomas.
STAT
JUNE 15, 2023
It’s to be expected, says two-time Pro Bowler Julius Thomas, that “colliding into other people for a living” might result in some long-term injuries. But among former NFL players, Black athletes report worse and more disruptive chronic pain than white players, according to a new study Thomas co-authored with researchers at Harvard and Brigham & Women’s Hospital.
Hospital Pharmacy Europe
JUNE 15, 2023
Oseltamivir use does not lower the risk of hospitalisation among older and high-risk patients with influzena, according to the findings of a recent systematic review and meta-analysis. Published in JAMA Internal Medicine , researchers examined whether oseltamivir use in adult and adolescent outpatients with influenza reduced the risk of hospitalisation.
ISPE
JUNE 15, 2023
Manufacturing Execution Systems & Electronic Production Records Management: A Building Block for Pharma 4.0™ & Your Organisation’s Digitlization Journey Trudy Patterson Thu, 06/15/2023 - 09:27 iSpeak Blog iSpeak Manufacturing Execution Systems & Electronic Production Records Management: A Building Block for Pharma 4.0™ & Your Organisation’s Digitlization Journey Paul J.
Fierce Pharma
JUNE 15, 2023
As biosimilars gradually gain steam in the U.S. market, one of the biggest manufacturers of the copycat biologics has unveiled a plan to boost uptake across the globe. | Sandoz' Act4Biosimilars action plan includes a detailed report of challenges preventing wider biosimilar access in each region, starting with the Americas. The initiative's steering group will work with stakeholders across the region to implement steps to boost uptake.
Drug Store News
JUNE 15, 2023
Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program.
STAT
JUNE 15, 2023
The homicide rate for older U.S. teenagers rose to its highest point in nearly 25 years during the COVID-19 pandemic, and the suicide rate for adults in their early 20s was the worst in more than 50 years, government researchers said Thursday. The Centers for Disease Control and Prevention report examined the homicide and suicide rates among 10- to 24-year-olds from 2001 to 2021.
Fierce Pharma
JUNE 15, 2023
An announcement early this month by Mark Cuban’s deep discount drug company that it would sell Coherus Biosciences’ biosimilar version of AbbVie’s Humira has the Illinois drugmaker calling foul.
STAT
JUNE 15, 2023
We have a knack in the U.S. for blurring behavior and medicine. Look at weight. For a long time, we’ve treated obesity as a moral failing, a lack of willpower. That was wrong. Now we’re treating weight as a medical issue that can be cured by pill or injection. Is this any better? Up to 130 million Americans could qualify for Ozempic or other GLP-1s (glucagon-like peptides), which cost nearly $1,000 per month.
The People's Pharmacy
JUNE 15, 2023
If you are like us, you welcome the first warm days of the season with joy. And then you start to fret. How can you keep the ticks from biting? Many people recognize Lyme disease as a serious health threat from deer tick bites. Fewer are aware that a bite from a completely different tick, the lone star tick, can lead to a mysterious meat allergy that may disrupt their lives.
STAT
JUNE 15, 2023
The U.S. Department of Agriculture is launching a program to ensure food producers substantiate claims that their animals are not raised on antibiotics, a move that reflects ongoing concerns that unnecessary use of these medicines causes resistance among humans. The agency will conduct a sampling project to assess antibiotic residues in cattle destined for the so-called raised without antibiotics market.
Fierce Pharma
JUNE 15, 2023
Astellas' new CEO Naoki Okamura talked to Fierce Pharma about the company's business plans. | Astellas' new CEO Naoki Okamura discussed the company's business plans. Eisai and Biogen's Leqembi won backing from the FDA's external advisers. AbbVie has brought a BTK patent infringement lawsuit against BeiGene. And more.
Expert insights. Personalized for you.
222 
Let's personalize your content